comparemela.com
Home
Live Updates
Adhoc: Relief Therapeutics Holding SA: Relief Signs a Definitive Agreement to Acquire a Novel Dosage Form of an Already Approved Prescription Drug for the Treatment of PKU : comparemela.com
Adhoc: Relief Therapeutics Holding SA: Relief Signs a Definitive Agreement to Acquire a Novel Dosage Form of an Already Approved Prescription Drug for the Treatment of PKU
Relief Therapeutics Holding SA / Key word(s): Acquisition Relief Signs a Definitive Agreement to Acquire a Novel Dosage Form of an Already Approved Prescription Drug for the Treatment of PKU 13-Jul-2022
Related Keywords
Geneva ,
Genè ,
Switzerland ,
Secheron ,
Switzerland General ,
United Kingdom ,
Swiss ,
Paolo Galfetti ,
Michael Miller ,
Raghuram Ram Selvaraju ,
Jack Weinstein ,
Advita Lifescience Gmb ,
Relief Therapeutics Holding Sa Key ,
Pharma Research ,
Drug Administration ,
Swiss Exchange ,
Meta Healthcare Ltd ,
Rx Communications Group ,
Exchange Commission ,
Relief Therapeutics Holding ,
News Service ,
Definitive Agreement ,
Novel Dosage Form ,
Already Approved Prescription Drug ,
Meta Healthcare ,
Chief Executive Officer ,
Investigational New Drug ,
License Agreement ,
Acer Therapeutics ,
Maple Syrup Urine Disease ,
Advita Lifescience Gmbh ,
Financial Officer ,
Adhoc ,
Relief ,
Herapeutics ,
Molding ,
Signs ,
Efinitive ,
Agreement ,
Cquire ,
Novel ,
Dosage ,
Form ,
Already ,
Approved ,
Prescription ,
Drug ,
Treatment ,
comparemela.com © 2020. All Rights Reserved.